Fabiano Di Marco Selected Research

Fabiano Di Marco Research Topics

Disease

38	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 01/2004
17	COVID-19 12/2023 - 01/2020
14	Asthma (Bronchial Asthma) 01/2024 - 02/2010
7	Tuberous Sclerosis (Bourneville's Disease) 11/2021 - 01/2016
6	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 06/2022 - 01/2016
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2023 - 01/2010
4	Lung Diseases (Lung Disease) 01/2023 - 02/2015
4	Rare Diseases (Rare Disease) 06/2022 - 07/2017
4	Dyspnea (Shortness of Breath) 01/2018 - 01/2004
3	Respiratory Insufficiency (Respiratory Failure) 03/2022 - 12/2018
3	Hypoxia (Hypoxemia) 01/2018 - 08/2007
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 07/2012
2	Rhinosinusitis 01/2024 - 01/2022
2	Pathologic Constriction (Stenosis) 12/2023 - 01/2023
2	Pneumonia (Pneumonitis) 03/2023 - 07/2012
2	Cysts 01/2021 - 01/2020
2	Inflammation (Inflammations) 11/2020 - 05/2014
2	Angiomyolipoma 01/2020 - 01/2016
2	Acute Lung Injury 01/2010 - 06/2009
1	Tracheal Stenosis 12/2023
1	Idiopathic Pulmonary Fibrosis 01/2023
1	Necrosis 01/2023
1	Ischemia 01/2023
1	Fatigue 01/2023
1	Nasal Polyps (Nasal Polyp) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Disease Progression 12/2021
1	Pulmonary Embolism 03/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Severe Acute Respiratory Syndrome 11/2020
1	Drug-Related Side Effects and Adverse Reactions 11/2020
1	Lung Injury 11/2020
1	Thrombotic Microangiopathies 11/2020

Drug/Important Bio-Agent (IBA)

17	Bronchodilator Agents (Bronchodilators)IBA 05/2023 - 01/2004
15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2017
10	Formoterol Fumarate (Oxis)FDA Link 01/2021 - 01/2004
7	benralizumabIBA 01/2024 - 01/2020
7	lipoarabinomannan (LAM)IBA 06/2022 - 01/2016
7	trans-sodium crocetinate (crocetin)IBA 11/2021 - 01/2016
7	Tiotropium Bromide (Spiriva)FDA Link 03/2012 - 01/2004
6	Muscarinic AntagonistsIBA 12/2019 - 01/2016
5	GoldIBA 03/2021 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 07/2012
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2021 - 11/2005
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 05/2009
3	Carbon MonoxideIBA 02/2015 - 01/2010
3	Salmeterol Xinafoate (Serevent)FDA Link 02/2012 - 01/2004
2	AnticoagulantsIBA 12/2021 - 03/2021
2	PTX3 proteinIBA 09/2021 - 01/2021
2	siltuximabIBA 09/2021 - 01/2021
2	Interleukin-8 (Interleukin 8)IBA 09/2021 - 01/2021
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021 - 01/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2019 - 08/2007
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2017 - 01/2004
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 10/2016 - 12/2015
2	Albuterol (Salbutamol)FDA LinkGeneric 06/2009 - 01/2004
1	mepolizumabIBA 01/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	Omalizumab (Xolair)FDA Link 01/2024
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	nintedanibIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 10/2022
1	Tuberous Sclerosis Complex 2 ProteinIBA 06/2022
1	TOR Serine-Threonine KinasesIBA 06/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2022
1	RoflumilastIBA 01/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	apremilastIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Clostridium perfringens epsilon-toxinIBA 10/2021
1	AerosolsIBA 02/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	E 10 (E-10)IBA 01/2021
1	eculizumab FDA Link 01/2021
1	Complement System Proteins (Complement)IBA 11/2020
1	Serine (L-Serine)FDA Link 11/2020
1	narsoplimabIBA 11/2020
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2020

Therapy/Procedure

23	Therapeutics 04/2024 - 05/2009
5	Nebulizers and Vaporizers (Inhaler) 01/2020 - 01/2004
4	Noninvasive Ventilation 07/2022 - 01/2011
4	Continuous Positive Airway Pressure 12/2021 - 12/2019
4	Artificial Respiration (Mechanical Ventilation) 12/2020 - 06/2009
3	Mechanical Ventilators (Ventilator) 01/2021 - 01/2011
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 07/2020 - 01/2010
2	Biological Therapy 01/2024 - 01/2022
2	Tracheostomy 12/2023 - 06/2010
2	Lung Transplantation 03/2023 - 01/2023
2	Precision Medicine 03/2021 - 12/2017
1	Contraindications 03/2023
1	Stents 01/2023
1	Electronic Nose 03/2022